Rare diseases
Investigational molecules
Locations
Back to Spain445 clinical trials in Galdakao, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children
SpainStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy
SpainEfficacy of comekibart Injection in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
SpainEfficacy and Safety of Rezpegaldesleukin (NKTR-358) in Patients Aged ≥12 Years with Moderate-to-Severe Atopic Dermatitis
SpainRandomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis
SpainPhase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis
SpainA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
SpainStudy on TAK-861 for Treating Narcolepsy with Cataplexy in Patients
SpainStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
SpainPhase 3 Study of trastuzumab brengitecan versus platinum‑based chemotherapy in adults with HER2‑positive metastatic urothelial cancer after anti‑PD‑(L)1 therapy
SpainLong‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
SpainStudy of Daily Oral Ibutamoren Mesilate in Treatment‑Naïve Prepubertal Children with Growth Hormone Deficiency
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on breast cancer treatments, including trials for HER2-positive and triple-negative variants. Research encompasses innovative therapies for pancreatic adenocarcinoma and colon cancer.
Multiple trials evaluating novel drug combinations and targeted therapies for improved patient outcomes.
Comprehensive research into pulmonary fibrosis and respiratory conditions, with studies examining new treatments for COPD and pulmonary embolism management.
Innovative approaches to improve lung function and patient quality of life.
Investigations into cardiomyopathy prevention and treatment, including trials for acute coronary syndromes and peripheral arterial disease management.
Focus on preventive strategies and improved treatment protocols for heart conditions.
Studies addressing endocrine disorders, including hypothyroidism and its effects. Research on hepatic conditions and smoking cessation therapies.
Diverse therapeutic approaches targeting various medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
